Robert E. Gagnon is Director of Verastem, Inc.. Currently has a direct ownership of 34,892 shares of VSTM, which is worth approximately $155,618. The most recent transaction as insider was on Dec 20, 2021, when has been sold 5,497 shares (Common Stock) at a price of $2.27 per share, resulting in proceeds of $12,478. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 34.9K
1.18% 3M change
25.17% 12M change
Total Value Held $155,618

Robert E. Gagnon Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 20 2021
SELL
Open market or private sale
$12,478 $2.27 p/Share
5,497 Reduced 0.94%
578,901 Common Stock
Dec 15 2021
BUY
Grant, award, or other acquisition
-
148,500 Added 20.26%
584,398 Common Stock
Aug 12 2021
SELL
Payment of exercise price or tax liability
$130,094 $2.87 p/Share
45,329 Reduced 9.42%
435,898 Common Stock
Dec 18 2020
BUY
Grant, award, or other acquisition
-
67,925 Added 10.62%
571,635 Common Stock

Also insider at

BBLG
Bone Biologics Corp Healthcare
REG

Robert E. Gagnon

Director
Needham, MA

Track Institutional and Insider Activities on VSTM

Follow Verastem, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VSTM shares.

Notify only if

Insider Trading

Get notified when an Verastem, Inc. insider buys or sells VSTM shares.

Notify only if

News

Receive news related to Verastem, Inc.

Track Activities on VSTM